(Q34547654)

2 August 2017

Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder (English)

1 reference

post-traumatic stress disorder

2 August 2017

1 reference

1 reference

Aimee L McRae

1

1 reference

2 August 2017

Kathleen T Brady

2

1 reference

2 August 2017

Thomas A Mellman

3

1 reference

2 August 2017

Susan C Sonne

4

1 reference

2 August 2017

Therese K Killeen

5

1 reference

2 August 2017

Mary Ann Timmerman

6

1 reference

2 August 2017

Wendy Bayles-Dazet

7

1 reference

2 August 2017

1 January 2004

1 reference

2 August 2017

Depression and Anxiety

1 reference

2 August 2017

19

1 reference

2 August 2017

190-196

1 reference

2 August 2017

3

1 reference

The effects of nefazodone on sleep architecture in depression

2 August 2017

1 reference

The assessment of anxiety states by rating

21 January 2018

1 reference

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

Assessing psychiatric impairment in primary care with the Sheehan Disability Scale

21 January 2018

1 reference

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

21 January 2018

1 reference

7 January 2021

The development of a Clinician-Administered PTSD Scale

1 reference

7 January 2021

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

7 January 2021

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

7 January 2021

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

7 January 2021

Assessment of a new self-rating scale for post-traumatic stress disorder

1 reference

7 January 2021

The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder.

1 reference

7 January 2021

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

7 January 2021

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

7 January 2021

Social anxiety: from laboratory studies to clinical practice

1 reference

7 January 2021

Comprehensive review of the psychiatric uses of valproate

1 reference

7 January 2021

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

1 reference

7 January 2021

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

7 January 2021

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

7 January 2021

Carbamazepine for PTSD

1 reference

7 January 2021

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

7 January 2021

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.

1 reference

7 January 2021

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

1 reference

7 January 2021

Nefazodone in patients with treatment-refractory posttraumatic stress disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20008

1 reference

2 August 2017

1 reference